Susan Benton

Susan Benton is a declared insider of Opus Genetics, Inc. (board member), with filings sourced from SEC (Form 4). Between 1 July 2021 and 20 April 2026, the trades on record add up to 13 filings.

The open-market record is one-sided, with 1 purchase worth €77k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 12 share grants.

The latest filing, published on 22 April 2026, reports a share grant in Opus Genetics, Inc. The last purchase on record was published on 3 September 2021, which is 1,871 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.